About 200 reports

THE REPOSITORY CONTAINS MORE THAN ##, ## CELL LINES AND ##, ## DNA SAMPLES FROM HEALTHY INDIVIDUALS AS WELL AS INDIVIDUALS WITH GENETIC DISEASES.

  • Cell Therapy
  • Hospital
  • Tissue Banking
  • Forecast
  • Market Segment

Researchers have found that heart-on-chip can be adopted to model human genetic diseases or to screen for an individual' s reaction to drugs.

  • Cell Therapy
  • World
  • AstraZeneca PLC
  • Nortis, Inc.
  • Roche Group

NORTH AMERICA CELL EXPANSION MARKET FIGURE ##: NORTH AMERICA DISEASES OUTLOOK ## Millions of Americans are Suffering With Auto- Immune Diseases. ## Millions of Americans Have At least One Chronic Disease. ## new cases of hemophilia due to FVIII added in 2017 in Canada.

  • Cell Therapy
  • Diabetes
  • North America
  • World
  • Becton Property Group
  • RECENT PARTNERSHIPS: YEAR-WISE TREND BY THERAPEUTIC AREA
  • lists the various encapsulated cell therapies and affiliated technologies (in alphabetical

OTHER POPULAR THERAPEUTIC AREAS FOR WHICH SUCH CELL THERAPIES ARE BEING DEVELOPED INCLUDE CANCER (##), EYE DISORDERS (##), NEUROLOGICAL DISORDERS (##), AND GENETIC DISORDERS (##).

  • Cell Therapy
  • Hospital
  • United States
  • Erytech Pharma SA
  • Neurotech Pharmaceuticals, Inc.
  • NORTH AMERICA: HUMANIZED MOUSEMODELS MARKET FORHEMATOPOIESIS, BY COUNTRY,2015-2022 (USD MILLION)
  • EUROPE: HUMANIZEDMOUSE MODELS MARKET FORHEMATOPOIESIS, BY REGION, 2015-2022 (USD MILLION)

The grant aimed at studying the changes in the immune system and the genetic profile of human diseases.

  • Cell Therapy
  • Colorectal Cancer
  • North America
  • United States
  • Horizon Discovery

The company is offering various technologies to diagnose genetic diseases, and it has a robust portfolio.

  • Cell Therapy
  • Colorectal Cancer
  • World
  • Forecast
  • Market Size

These are manufactured by the expression of proteins from genetically engineered cell lines.

  • Cell Therapy
  • China
  • East Asia
  • Biotest AG
  • Grifols, S.A.
  • OTHERS
  • MARKET DRIVERS

This technique is used to design therapies for genetic disorders, spinal cord injuries, degenerative diseases, and cancer.

  • Cell Therapy
  • World
  • Forecast
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Highest development stage
  • 3.5.6 BIOLOGIC FOR LYSOSOMAL STORAGE DISORDER - EXERKINE

Duchenne muscular dystrophy is a genetic disorder that occurs in approximately one in every ##, ## live male births, globally.

  • Cell Therapy
  • CAP-1002 group
  • Capricor Therapeutics, Inc.
  • Mirna Therapeutics, Inc.
  • ReNeuron Group plc
  • 1.1 Colorectal Cancer

Most colorectal cancers are due to old age and lifestyle factors with only a small number of cases with underlying genetic disorders.

  • Colorectal Cancer
  • United States
  • Forecast
  • Epigenomics AG
  • Exact Sciences Corp.
  • OTHERS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018 V'S 2025) ($BN)
  • Date

TO DATE, OVER ## GENETIC DISEASES HAVE BEEN DESCRIBED IN THE DOG.

  • Cell Therapy
  • Abzena plc
  • Biologics, Inc.
  • Horizon Discovery
  • Merck & Co., Inc.
  • CRISPR TECHNOLOGY SEGMENT TO DOMINATE MICE MODEL MARKET IN 2016

This is a genetic metabolism disorder which prohibits the proper breakdown of the body' s sugar molecules, one of a group of diseases called mucopolysaccharidoses.

  • Cell Therapy
  • Colorectal Cancer
  • Charles River Laboratories International, Inc.
  • genOway SA
  • Taconic Biosciences, Inc.
  • DEVELOPMENT OF GENE AND CELL THERAPY-BASED PRODUCTS

Hemophilia is a genetic disorder attributed to gene mutations.

  • Cell Therapy
  • Biogen Idec Inc.
  • Novo Nordisk Group
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

More than ##% of rare diseases are genetic in origin, so that gene and cell therapies are being proposed to treat them.

  • Biopharmaceutical
  • Cell Therapy
  • Medical Biotechnology
  • M&A
  • Market outline

Cancer is not just one disease but it is a combination of diseases.

  • Cell Therapy
  • GE Healthcare Limited
  • Lonza Group Ltd
  • Millipore Corporation
  • Thermo Fisher Scientific, Inc.

The diseases targeted include macular degeneration, Parkinson’s disease, type I diabetes mellitus, and spinal cord injury.

  • Biopharmaceutical
  • Cell Therapy
  • Medical Biotechnology
  • United States
  • 2. EXECUTIVE SUMMARY
  • 10. ROLE OF NON-PROFIT ORGANIZATIONS

IT IS WORTH MENTIONING THAT MOST OF THE AFOREMENTIONED PRODUCTS TARGET CANCER AND GENETIC DISORDERS.

  • Cell Therapy
  • Colorectal Cancer
  • World
  • Market Size
  • Lonza Group Ltd
  • MAR 07, 2018: BOOSTING BRAIN'S IMMUNE CELL FUNCTION IMPROVES ALZHEIMER'S SYMPTOMS IN MICE, STUDY FINDS

" Cancer isn' t a one-size-fits all disease.

  • Cell Therapy
  • Colorectal Cancer
  • Medical Biotechnology
  • Therapy
  • United States
  • OTHER PROMINENT VENDORS

The company develops transformative gene therapies for genetic diseases.

  • Cell Therapy
  • Colorectal Cancer
  • Dendreon Corporation
  • Mesoblast Limited
  • Vericel Corporation

RP is a rare genetic eye disorder with limited clinical research prior to 2010.

  • Cell Therapy
  • Medical Biotechnology
  • United States
  • Novartis AG
  • Novelion Therapeutics Inc.

AUTOLOGOUS CORD BLOOD CARRIES THE SAME GENETIC DEFECTS AS THE DONOR AND SHOULD NOT BE USED TO TREAT GENETIC DISEASES.

  • Cell Therapy
  • United States
  • AMAG Pharmaceuticals, Inc.
  • Anthrogenesis Corp.
  • Cryo-Save Group N.V.

RESEARCH GENOME EDITING AND GENE THERAPIES FOR SEVERE GENETIC AND RARE DISEASE.

  • Cell Therapy
  • Cellectis S.A.
  • Horizon Discovery
  • Merck & Co., Inc.
  • Sangamo BioSciences, Inc.
  • 8.4. EUROPEAN COLLECTION OF AUTHENTICATED CELL CULTURES (ECACC) 8.4.1. OVERVIEW

It is one of the simplest, most versatile and precise methods of genetic manipulation.

  • Cell Therapy
  • Colorectal Cancer
  • Abzena plc
  • Lonza Group Ltd
  • Selexis SA
  • 3.3 FACTORS INFLUENCING MARKET
  • INDUCED PLURIPOTENT STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)

Examples include mental disorders, vision and hearing impairment, oral diseases, bone and joint disorders, and genetic disorders.

  • Cell Therapy
  • Colorectal Cancer
  • World
  • Market Size
  • Eppendorf AG

Journal of Global Infectious Diseases; ##(##): ##- ##.

  • Cell Therapy
  • Colorectal Cancer
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • RAT MODEL MARKET, BY TECHNOLOGY, 2016-2021
  • 9.1 INTRODUCTION

Sanfilippo Syndrome is a genetic metabolism disorder that prohibits the proper breakdown of the body' s sugar molecules, one of a group of diseases called mucopolysaccharidoses (MPS).

  • Cell Therapy
  • Colorectal Cancer
  • Charles River Laboratories International, Inc.
  • genOway SA
  • Horizon Discovery
  • Introduction

For instance, in 2003, Genetic Alliance provided infrastructure to patient advocacy groups conducting research on rare diseases.

  • Cell Therapy
  • World
  • Beckman Coulter, Inc.
  • BioCision, LLC
  • Thermo Fisher Scientific, Inc.
  • 2.2.2. MESOBLAST (WWW.MESOBLAST.COM)
  • 2. Cell Therapy Companies Worldwide

Oncology - Improving outcomes of bone marrow transplantation in patients with cancer intervertebral discs or generate new bone or genetic diseases.

  • Cell Therapy
  • Mesoblast Limited
  • Pluristem Therapeutics Inc.
  • PROVENGE group
  • TiGenix NV

PROPORTION OF ADRENOLEUKODYSTROPHY (ADRENOMYELONEUROPATHY/ SCHILDER-ADDISON COMPLEX) TO GENETIC DISORDERS CLINICAL TRIALS, E## COUNTRIES (%), 2018* PROPORTION OF ADRENOLEUKODYSTROPHY (ADRENOMYELONEUROPATHY/ SCHILDER-ADDISON COMPLEX) TO GENETIC DISORDERS C

  • Cell Therapy
  • Clinical Trial
  • Dementia
  • World
  • Product Initiative

These include reprogramming, which helps to create stem cells for any disease type; creating in vitro model systems caused by known genetic mutations; and expanding the identification of stem cell niches among most adult stem cells, which provides another source of cells used to mo

  • Cell Therapy
  • Cynata Therapeutics Limited
  • Mesoblast Limited
  • NuVasive, Inc.
  • Orthofix International N.V.